Scienture Holdings, Inc. (SCNX)
SCNX Stock Price Chart
Explore Scienture Holdings, Inc. interactive price chart. Choose custom timeframes to analyze SCNX price movements and trends.
SCNX Company Profile
Discover essential business fundamentals and corporate details for Scienture Holdings, Inc. (SCNX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
6 Feb 2014
Employees
14.00
Website
https://www.trxadehealth.comCEO
Shankar Hariharan
Description
As a health services IT enterprise, TRxADE HEALTH, Inc. manages an online platform designed to facilitate transactions between licensed pharmaceutical wholesalers and healthcare providers. This digital marketplace enables wholesalers to distribute a broad spectrum of products and services, encompassing branded and generic drugs as well as other non-pharmaceutical items. Customers for these offerings span government organizations, hospitals, medical clinics, and independent pharmacies. The firm's corporate base is situated in Tampa, Florida.
SCNX Financial Timeline
Browse a chronological timeline of Scienture Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 17 Aug 2026
EPS estimate is -$0.09, while revenue estimate is $1.96m.
Earnings released on 11 May 2026
EPS came in at -$0.08 surpassing the estimated -$0.23 by +65.22%, while revenue for the quarter reached $56.33k , missing expectations by -85.95%.
Earnings released on 24 Mar 2026
EPS came in at -$1.76 falling short of the estimated -$0.22 by -700.00%, while revenue for the quarter reached -$168.70k , missing expectations by -134.68%.
Earnings released on 12 Nov 2025
EPS came in at -$0.19 , while revenue for the quarter reached $590.05k .
Earnings released on 12 Aug 2025
EPS came in at -$0.48 .
Earnings released on 12 May 2025
EPS came in at -$0.33 , while revenue for the quarter reached $10.26k .
Earnings released on 26 Mar 2025
EPS came in at -$0.82 , while revenue for the quarter reached $53.08k , missing expectations by -97.91%.
Earnings released on 6 Nov 2024
EPS came in at -$1.34 falling short of the estimated -$0.15 by -793.33%, while revenue for the quarter reached $64.86k , missing expectations by -97.38%.
Earnings released on 9 Aug 2024
EPS came in at -$1.04 falling short of the estimated -$0.15 by -593.33%, while revenue for the quarter reached $18.70k , missing expectations by -99.18%.
Dividend declared on 19 Jul 2024
A dividend of $1.50 per share was announced, adjusted to $1.50. The dividend was paid on 24 Jul 2024.
Earnings released on 26 Jun 2024
EPS came in at -$6.40 falling short of the estimated -$0.15 by -4.17k%.
Dividend declared on 25 Mar 2024
A dividend of $8.00 per share was announced, adjusted to $8.00.
Earnings released on 31 Dec 2023
EPS came in at -$4.93 , while revenue for the quarter reached $2.35m .
Earnings released on 30 Sept 2023
EPS came in at -$1.49 falling short of the estimated -$0.15 by -894.43%, while revenue for the quarter reached $392.29k , missing expectations by -82.79%.
Earnings released on 30 Jun 2023
EPS came in at -$2.90 falling short of the estimated -$0.75 by -286.55%, while revenue for the quarter reached $366.53k , missing expectations by -82.21%.
Stock split effective on 22 Jun 2023
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Mar 2023
EPS came in at -$1.01 falling short of the estimated -$0.30 by -236.93%, while revenue for the quarter reached $493.32k , missing expectations by -81.43%.
Earnings released on 31 Dec 2022
EPS came in at -$1.50 falling short of the estimated -$0.90 by -66.40%, while revenue for the quarter reached $2.53m , beating expectations by +0.64%.
Earnings released on 30 Sept 2022
EPS came in at -$0.91 , while revenue for the quarter reached $2.06m .
Earnings released on 30 Jun 2022
EPS came in at -$1.99 falling short of the estimated -$1.73 by -15.19%, while revenue for the quarter reached $3.28m , missing expectations by -0.49%.
Earnings released on 31 Mar 2022
EPS came in at -$1.76 , while revenue for the quarter reached $3.24m .
Earnings released on 31 Dec 2021
EPS came in at -$1.44 , while revenue for the quarter reached $2.39m .
Earnings released on 30 Sept 2021
EPS came in at -$2.39 , while revenue for the quarter reached $2.55m .
SCNX Stock Performance
Access detailed SCNX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
